Hsp Inhibitor is Affective Against Adenocarcinomic Human Alveolar Basal Epithelial Cells Through Modulating ERK/MAPK Signaling Pathway
     
Yazarlar (6)
Servet Tunoğlu Istanbul Üniversitesi, Türkiye
Dr. Öğr. Üyesi Lütfi TUTAR Kırşehir Ahi Evran Üniversitesi, Türkiye
Mehmet Gümüş Yozgat Bozok Üniversitesi, Türkiye
Ezgi Nurdan Yenilmez Tunoğlu Demiroglu Science University, Türkiye
İrfan Koca Yozgat Bozok Üniversitesi, Türkiye
Yusuf Tutar Recep Tayyip Erdoğan Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Chemistry and Biodiversity (Q3)
Dergi ISSN 1612-1872 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 01-2024
Cilt / Sayı / Sayfa 21 / 2 / – DOI 10.1002/cbdv.202301422
Makale Linki https://doi.org/10.1002/cbdv.202301422
Özet
The extracellular signal‐regulated kinase (ERK) ‐ mitogen‐activated protein kinase (MAPK) pathway regulates cell proliferation, differentiation, and apoptosis. Heat Shock Protein 90 (HSP90) is required to activate proto‐oncogenic protein kinases and promotes tumor growth through anti‐apoptotic effects on A549‐non‐small cell lung cancer (NSCLC). Therefore, deregulation of the ERK‐MAPK pathway and abnormal expression of HSP90 are reasonably frequent events in NSCLC. In this study, novel perimidine‐pyrazole compounds employed to block ERK‐MAPK deregulation through inhibiting HSP dependent cancer cell survival mechanisms. A set of perimidine‐pyrazole derivatives effects was monitored on NSCLC cell line. Array experiments performed to understand the effect of the compounds on signaling pathways and results were analyzed by gene enrichment analysis. Further, senescence and apoptosis …
Anahtar Kelimeler
Senescence | Apoptosis | Perimidine-pyrazole | NSCLC | A549 | HSP